Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 22.
doi: 10.1111/pai.13262. Online ahead of print.

Managing Childhood Allergies and Immunodeficiencies During Respiratory Virus Epidemics - The 2020 COVID-19 Pandemic


Managing Childhood Allergies and Immunodeficiencies During Respiratory Virus Epidemics - The 2020 COVID-19 Pandemic

Helen A Brough et al. Pediatr Allergy Immunol. .


While the world is facing an unprecedented pandemic with COVID-19, patients with chronic diseases need special attention and if warranted adaptation of their regular treatment plan. In children, allergy and asthma are among the most prevalent non-communicable chronic diseases, and health care providers taking care of these patients need guidance. At the current stage of knowledge, children have less severe symptoms of COVID-19, and severe asthma and immunodeficiency are classified as risk factors. In addition, there is no evidence that currently available asthma and allergy treatments, including antihistamines, corticosteroids, bronchodilators increase the risk of severe disease from COVID-19. Most countries affected by COVID-19 have opted for nationwide confinement, which means that communication with the primary clinician is often performed by telemedicine. Optimal disease control of allergic, asthmatic and immunodeficient children should be sought according to usual treatment guidelines. This statement of the EAACI Section on Pediatrics puts forward six recommendations for the management of childhood allergies and immunodeficiencies based on six underlying facts and existing evidence.

Keywords: COVID-19; SARS-CoV-2; allergy; asthma; biologics; children; coronavirus; corticosteroids; immunodeficiency; treatment.

Similar articles

  • Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, Choolani M, Mattar C, Su LL. Dashraath P, et al. Am J Obstet Gynecol. 2020 Mar 23:S0002-9378(20)30343-4. doi: 10.1016/j.ajog.2020.03.021. Online ahead of print. Am J Obstet Gynecol. 2020. PMID: 32217113
  • Features, Evaluation and Treatment Coronavirus (COVID-19).
    Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Cascella M, et al. 2020 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32150360 Free Books & Documents. Review.
  • A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. Al-Shamsi HO, et al. Oncologist. 2020 Apr 3. doi: 10.1634/theoncologist.2020-0213. Online ahead of print. Oncologist. 2020. PMID: 32243668
  • COVID-19, asthma, and biologic therapies: What we need to know.
    Morais-Almeida M, Aguiar R, Martin B, Ansotegui IJ, Ebisawa M, Arruda LK, Caminati M, Canonica GW, Carr T, Chupp G, Corren J, Dávila I, Park HS, Hanania NA, Rosenwasser L, Sánchez-Borges M, Virchow JC, Yáñez A, Bernstein JA, Caraballo L, Chang YS, Chikhladze M, Fiocchi A, González-Diaz SN, Tanno LK, Levin M, Ortega-Martell JA, Passalacqua G, Peden DB, Rouadi PW, Sublett JL, Wong GWK, Bleecker ER. Morais-Almeida M, et al. World Allergy Organ J. 2020 May 16:100126. doi: 10.1016/j.waojou.2020.100126. Online ahead of print. World Allergy Organ J. 2020. PMID: 32426090 Free PMC article. Review.
  • COVID-19 and Asthma: Reflection During the Pandemic.
    Liu S, Zhi Y, Ying S. Liu S, et al. Clin Rev Allergy Immunol. 2020 May 28. doi: 10.1007/s12016-020-08797-3. Online ahead of print. Clin Rev Allergy Immunol. 2020. PMID: 32468411 Review.
See all similar articles

LinkOut - more resources